Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance

Leukemia and Lymphoma

Volumn 48, Issue 2, 2007, Pages 337-341

  Eleutherakis Papaiakovou, V ^f   Bamias, A ^f   Gika, D ^f   Simeonidis, A ^a   Pouli, A ^b   Anagnostopoulos, A ^f   Michali, E ^c   Economopoulos, T ^d   Zervas, K ^e   Dimopoulos, M A ^f  

^a UNIVERSITY OF PATRAS   (Greece)

^b Agios Savvas Cancer Hospital   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

^e THEAGENIO CANCER HOSPITAL   (Greece)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BENCE JONES PROTEIN; BETA 2 MICROGLOBULIN; CORTICOSTEROID; CREATININE; DEXAMETHASONE; LACTATE DEHYDROGENASE;

AGE DISTRIBUTION; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER STAGING; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DATA BASE; DRUG MEGADOSE; FEMALE; HUMAN; INCIDENCE; INDEPENDENT VARIABLE; KIDNEY FAILURE; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE; UNIVARIATE ANALYSIS; BLOOD; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; CREATININE; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE; MALE; MULTIPLE MYELOMA; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34247897361     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190601126602     Document Type: Article

References (8)

1. Alexanian, R., Barlogie, B. and Dixon, D. (1990) Renal failure in multiple myeloma. Pathogenesis and prognostic implications. Arch Intern Med, 150, pp. 1693-1695.
2. Knudsen, L. M., Hippe, E., Hjorth, M. and Westin, J. (1994) Renal function in newly diagnosed multiple myeloma: A demographic study of 1353 patients. Eur J Haematol, 53, pp. 207-212.
3. Blade, J., Fernadez-Liama, P., Bosch, F., Montoliu, J., Lens, X. M. and Montoto, S. (1998) Renal failure in multiple myeloma. Arch Intern Med, 158, pp. 1889-1893.
4. Knudsen, L. M., Hjorth, M. and Hippe, E. (2000) Renal failure in multiple myeloma: Reversibility and impact on the prognosis. Eur J Haematol, 65, pp. 175-181.
5. Kyle, R. A., Gertz, M. A., Witzing, T. E., Lust, J. A., Lacy, M. Q. and Dispenzieri, A. (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc, 78, pp. 21-33.
6. Auguston, B. M., Begum, G., Dunn, J. A., Barth, N. J., Davies, F. and Morgan, G. (2005) Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party. J Clin Oncol, 23, pp. 9219-9226.
7. Miguel, J F San and Garcia-Sanz, R. (2005) Prognostic features of multiple myeloma. Best Pract Res Clin Haematol, 18, pp. 569-583.
8. Greipp, P. R., Miguel, J San, Durie, B. G., Crowley, J. J., Barlogie, B. and Blade, J. (2005) International staging system for multiple myeloma. J Clin Oncol, 23, pp. 3412-3420.